Torax Medical, Inc., a leader in therapeutic interventions for sphincter-related diseases, including gastroesophageal reflux disease (GERD), announced today the American Medical Association (AMA) has created a new Category 1 Current Procedural Terminology (CPT®) Code for esophageal sphincter augmentation using the LINX® Reflux Management System effective January 1, 2017. The LINX device is placed with a minimally invasive laparoscopic procedure and is intended to restore control of abnormal reflux.
http://www.businesswire.com/news/home/20151118005251/en/American-Medical-Association-Creates-Category-1-Code
American Medical Association Creates New Category 1 Code for Torax Medical's LINX Procedure to Treat Gastroesophageal Reflux Disease